Second swine flu vaccine given green light for October start

By Tom Moberly, 02 October 2009

Baxter's swine flu vaccine has been given the green light for approval by the European Medicines Agency (EMEA).

The EMEA has granted a 'positive opinion' for Baxter's Celvapan H1N1 pandemic vaccine. It will now need to be granted final marketing authorisation by the European Commission before being made available.

The UK government has contracts to buy swine flu vaccine from GSK and Baxter. GSK's vaccine Pandemrix was granted a 'positive opinion' last month.

England's chief medical officer Sir Liam Donaldson said this week that the vaccination programme would start in the second half of October 'if everything goes to plan'.

 

Send to a friend

Items with an asterisk * are required

blog comments powered by Disqus

Additional Information


 

Latest jobs Jobs web feed

More General Practice Jobs
 

MIMS Drug Search

Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.


Medical Conferences

Book your place or register your interest for our clinical conferences.